1493206
Last Update Posted: 2011-12-16
Recruiting has ended
All Genders accepted | 18 Years + |
32 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Prospective Single Arm Study of Intraoperative Radiotherapy for Locally Advanced or Recurrent Rectal Cancer
The hypothesis is that intraoperative radiotherapy for locally advanced or recurrent rectal cancer improve outcomes without causing significant side effects.
Primary Outcome measures are 3-year locoregional control, progression-free and overall survival rates.
Secondary outcome measures are toxicities scores up to 3 months after surgery (acute) and greater than 3 months after surgery (late). Data collected at 3-6 month intervals for 30 months
Eligibility
Relevant conditions:
Malignant Rectal Neoplasm
Recurrent Tumor
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
No valid contacts available
Data sourced from ClinicalTrials.gov